Skip to content
OpenCapital
Get started

Humacyte HUMA Q2 2025 earnings

Reported August 11, 2025 · Before market open

Revenue$301.0KMiss by $616.8K
EPS-$0.24Miss by $0.09
Revenue estimate$917.8K
EPS estimate-$0.15

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$1.1M
EPS estimate-$0.10

Versus estimates

Revenue

Q1 2026$495.0KMiss by $968.7KQ4 2025$467.0KMiss by $882.3KQ3 2025$753.0KMiss by $596.0K
Q2 2025$301.0KMiss by $616.8K
Q1 2025$517.0KMiss by $247.8KQ4 2024$7.2MBeat by $6.6M

Diluted EPS

Q1 2026-$0.09Beat by $0.01Q4 2025-$0.13In lineQ3 2025-$0.14Beat by $0.03
Q2 2025-$0.24Miss by $0.09
Q1 2025-$0.10Beat by $0.09Q4 2024-$0.16Beat by $0.07

Ask the moment Humacyte reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Humacyte report Q2 2025 earnings?
Humacyte (HUMA) reported Q2 2025 earnings on August 11, 2025 before market open.
What were Humacyte's Q2 2025 revenue and EPS?
Humacyte reported revenue of $301.0K and eps of $-0.24 for Q2 2025.
Did Humacyte beat estimates in Q2 2025?
Revenue missed the consensus estimate of $917.8K by $616.8K. EPS missed the consensus estimate of $-0.15 by $0.09.
How did Humacyte's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 11.1% from $-0.27.
Where can I find Humacyte's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001818382-25-000125) directly on SEC EDGAR. The filing index links above go to sec.gov.